Given the significant side effects of current Alzheimer’s treatments, targeting tyrosinase inhibition might offer a dual therapeutic strategy not only for skin aging but also for slowing the progression of Alzheimer’s disease. Here, TYR is linked to early-onset autosomal dominant Alzheimer disease.